L Duffett, LA Castellucci, MA Forgie - Bmj, 2020 - bmj.com
Pulmonary embolism is a common and potentially fatal cardiovascular disorder that must be promptly diagnosed and treated. The diagnosis, risk assessment, and management of …
K Keller, L Hobohm, M Ebner, KP Kresoja… - European heart …, 2020 - academic.oup.com
Aims Pulmonary embolism (PE) is the third most common cardiovascular cause of death; systemic thrombolysis is potentially lifesaving treatment in patients presenting with …
Background European estimates of the burden imposed by pulmonary embolism are not available to this date. We aimed to assess pulmonary embolism-related mortality and time …
Aims Patients with acute pulmonary embolism (PE) classified as low risk by the Pulmonary Embolism Severity Index (PESI), its simplified version (sPESI), or the Hestia criteria may be …
Background: The long-term effect of thrombolytic treatment of pulmonary embolism (PE) is unknown. Objectives: This study investigated the long-term prognosis of patients with …
The efficient progress in nanotechnology has transformed many aspects of food science and the food industry with enhanced investment and market share. Recent advances in …
Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a preventable cause of in-hospital death, and one of the most prevalent …
PK Henke, SR Kahn, CJ Pannucci, EA Secemksy… - Circulation, 2020 - Am Heart Assoc
Venous thromboembolism (VTE) is a major preventable disease that affects hospitalized inpatients. Risk stratification and prophylactic measures have good evidence supporting …
F Götzinger, L Lauder, ASP Sharp, IM Lang… - Nature Reviews …, 2023 - nature.com
Pulmonary embolism (PE) is the leading cause of in-hospital death and the third most frequent cause of cardiovascular death. The clinical presentation of PE is variable, and …